Nasal carriage of S. aureus: host-pathogen interactions
Nasal carriage of S. aureus: host-pathogen interactions
批准号:
7326788
负责人:
ALEXANDER MICHAEL COLE
金额:
$30.65万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-12-01 至 2010-11-30
关键词:
AffectAnterior naresAnti-Bacterial AgentsAntibiotic ResistanceAntibioticsApicalBacteriaBiologicalBiological MarkersChronicClinicalDevelopmentDiseaseEpithelialEpithelial CellsFrightHost DefenseHumanImmunologistIn VitroIndividualIntegration Host FactorsIronLactoferrinLinkLiquid substanceMicrobial BiofilmsMolecularMucous MembraneMuramidaseNasal EpitheliumNoseNosocomial InfectionsPeptidesPharmaceutical PreparationsPilot ProjectsPredisposing FactorProtein OverexpressionProteinsProteomicsPublic HealthResearch PersonnelResistanceRoleShapesSiderophoresSourceStaphylococcus aureusStructure of mucous membrane of noseStudy modelsSurfaceTestingTimeWorkantimicrobialbasecomparativein vivoinhibitor/antagonistinsightinterdisciplinary approachkillingslipocalin 1methicillin resistant Staphylococcus aureusnovelnovel strategiespathogenpolypeptidepreventprogramsprotein expressionreconstitutionresearch study
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Nasal carriage of Staphylococcus aureus (SA) is a common factor that predisposes individuals to severe
nosocomial infections, and acts as an important reservoir for harboring and spreading resistant strains. The
disorder affects nearly a quarter of apparently healthy people and its molecular and cellular bases are
unknown. Experiments from our pilot project revealed that SA nasal carriage may be due to impaired innate
antimicrobial activity of nasal fluid. The protein expression levels of a major host defense polypeptide,
lipocalin-1 (a scavenger of bacterial siderophores), was found to be reduced in human nasal fluid from
donors whose nasal passageways were colonized by SA. In antibacterial studies, lipocalin-1 worked in
concert with lysozyme to kill SA in vitro. Most importantly, lipocalin-1 could restore the intrinsic anti-SA
activity of non-carrier nasal fluid selectively depleted of cationic polypeptides, and the restorative activity
could be abolished by the addition of iron. In the aggregate, our findings clearly suggest an important
correlation of lipocalin-1 deficiency with SA carriage. We hypothesize that 1) the expression of lipocalin-1 is
dysregulated in the nasal mucosa of SA carriers, contributing to the progressive colonization of SA, 2)
correcting the lipocalin-1 deficiency will reconstitute the antimicrobial activity of SA carrier nasal fluid against
isolates of SA, and 3) SA augments the epithelial expression of lipocalin-1 and other host defense
molecules, which contributes to preferential colonization of SA on carrier mucosa as compared with non-
carrier mucosa. To test these hypotheses, we will: 1) Characterize the biological role of lipocalin-1 in SA
nasal carriage, 2) Examine the influence of bacterial and host factors on the expression and anti-SA activity
of lipocalin-1, and 3) Examine the contribution of human nasal epithelium to SA colonization. Our proposed
studies represent a biologically relevant approach to identify and link causative factors of human airway
disease (cationic polypeptide antimicrobials) with their effects (SA nasal carriage).
Relevance to Public Health: SA carriage is of increasing clinical importance because hospital-acquired
infections are commonly spread by people who carry antibiotic-resistant SA in their nostrils. Our studies will
characterize factors responsible for SA carriage, and will continue to develop a very useful and natural model
for studying the interactions of bacteria with a readily accessible mucosal surface in humans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Augmenting innate immunity to combat nasal carriage of Staphylococcus aureus
-
批准号:9241954
-
项目类别:
-
资助金额:$21.9万
-
财政年份:2016
-
负责人:ALEXANDER MICHAEL COLE
-
依托单位:
Augmenting innate immunity to combat nasal carriage of Staphylococcus aureus
-
批准号:9111552
-
项目类别:
-
资助金额:$18.25万
-
财政年份:2016
-
负责人:ALEXANDER MICHAEL COLE
-
依托单位:
Development of nonhuman primate model of S. aureus nasal carriage
-
批准号:8953176
-
项目类别:
-
资助金额:$26.14万
-
财政年份:2015
-
负责人:ALEXANDER MICHAEL COLE
-
依托单位:
Aminoglycoside microbicides restore natural expression of anti-HIV-1 retrocyclins
-
批准号:7935209
-
项目类别:
-
资助金额:$19.87万
-
财政年份:2009
-
负责人:ALEXANDER MICHAEL COLE
-
依托单位:
Development of RC-101 as an Intravaginal Anti-HIV-1 Topical Microbicide
-
批准号:7681867
-
项目类别:
-
资助金额:$40.24万
-
财政年份:2009
-
负责人:ALEXANDER MICHAEL COLE
-
依托单位:
Aminoglycoside microbicides restore natural expression of anti-HIV-1 retrocyclins
-
批准号:8514470
-
项目类别:
-
资助金额:$43.6万
-
财政年份:2009
-
负责人:ALEXANDER MICHAEL COLE
-
依托单位:
Aminoglycoside microbicides restore natural expression of anti-HIV-1 retrocyclins
-
批准号:8318565
-
项目类别:
-
资助金额:$47.1万
-
财政年份:2009
-
负责人:ALEXANDER MICHAEL COLE
-
依托单位:
Aminoglycoside microbicides restore natural expression of anti-HIV-1 retrocyclins
-
批准号:7665661
-
项目类别:
-
资助金额:$19.35万
-
财政年份:2009
-
负责人:ALEXANDER MICHAEL COLE
-
依托单位:
Aminoglycoside microbicides restore natural expression of anti-HIV-1 retrocyclins
-
批准号:8293813
-
项目类别:
-
资助金额:$46.74万
-
财政年份:2009
-
负责人:ALEXANDER MICHAEL COLE
-
依托单位:
Nasal carriage of S. aureus: host-pathogen interactions
-
批准号:7736782
-
项目类别:
-
资助金额:$30.34万
-
财政年份:2005
-
负责人:ALEXANDER MICHAEL COLE
-
依托单位:
DEVELOPMENT OF RETROCYCLIN MICROBICIDES
-
批准号:6955868
-
项目类别:
-
资助金额:$19.2万
-
财政年份:2005
-
负责人:ALEXANDER MICHAEL COLE
-
依托单位:
Nasal carriage of S. aureus: host-pathogen interactions
-
批准号:7046426
-
项目类别:
-
资助金额:$32.18万
-
财政年份:2005
-
负责人:ALEXANDER MICHAEL COLE
-
依托单位:
Nasal carriage of S. aureus: host-pathogen interactions
-
批准号:7149148
-
项目类别:
-
资助金额:$31.24万
-
财政年份:2005
-
负责人:ALEXANDER MICHAEL COLE
-
依托单位:
Nasal carriage of S. aureus: host-pathogen interactions
-
批准号:7535587
-
项目类别:
-
资助金额:$30.65万
-
财政年份:2005
-
负责人:ALEXANDER MICHAEL COLE
-
依托单位:
Proteomics of Staphylococcus aureus nasal carriage
-
批准号:6797078
-
项目类别:
-
资助金额:$15.25万
-
财政年份:2002
-
负责人:ALEXANDER MICHAEL COLE
-
依托单位:
Retrocyclins: Circular Defensins Active Against HIV-1
-
批准号:6553586
-
项目类别:
-
资助金额:$34.33万
-
财政年份:2002
-
负责人:ALEXANDER MICHAEL COLE
-
依托单位:
Retrocyclins: circular defensins active against HIV-1
-
批准号:7418927
-
项目类别:
-
资助金额:$34.27万
-
财政年份:2002
-
负责人:ALEXANDER MICHAEL COLE
-
依托单位:
Proteomics of Staphylococcus aureus nasal carriage
-
批准号:6531771
-
项目类别:
-
资助金额:$15.26万
-
财政年份:2002
-
负责人:ALEXANDER MICHAEL COLE
-
依托单位:
Retrocyclins: circular defensins active against HIV-1
-
批准号:7628382
-
项目类别:
-
资助金额:$34.27万
-
财政年份:2002
-
负责人:ALEXANDER MICHAEL COLE
-
依托单位:
Retrocyclins: circular defensins active against HIV-1
-
批准号:7061054
-
项目类别:
-
资助金额:$37.26万
-
财政年份:2002
-
负责人:ALEXANDER MICHAEL COLE
-
依托单位: